Zolpidem Tartrate Tablet
Product Images NDC 60760-515

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate (NDC 60760-515). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Zolpidem 60760 515 60

Packaging label for Zolpidem Tartrate 5 mg tablets, USP, quantity 60, manufactured by Torrent Pharmaceuticals Ltd, India, and packaged by St. Mary's Medical Park Pharmacy, Oro Valley, AZ. The label includes placeholders for lot number, expiration date, and prescription number. Storage instructions specify controlled room temperature between 15°-30°C (59°-86°F).*

FDA Label Image

Image 1 (Zolpidem 01)

Chemical structure of zolpidem tartrate showing the molecular arrangement of the active ingredient zolpidem tartrate in its tablet formulation by St. Mary's Medical Park Pharmacy.*

FDA Label Image

Logo (Zolpidem 02)

ZOLPIDEM TARTRATE 5 mg oral tablets in a blister pack. The packaging shows a grid of 10 tablets arranged in two rows of five. The label includes the drug name, strength, dosage form, and the labeler, St. Mary's Medical Park Pharmacy.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.